Literature DB >> 21370600

Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer.

Mi-Kyung Kim1, Hoenil Jo, Hyoun-Joong Kong, Hee Chan Kim, Jae Weon Kim, Yong-Man Kim, Yong-Sang Song, Soon-Beom Kang, Jung-Eun Mok, Hyo Pyo Lee.   

Abstract

OBJECTIVE: The aim of this study was to develop a nomogram for predicting the 5-year disease-free survival (DFS) after radical hysterectomy for early-stage cervical cancer. PATIENTS AND METHODS: An institutional database of 275 consecutive patients treated at Seoul National University Hospital for stage I to stage IIA cervical cancer was used to develop a nomogram based on Cox proportional hazards regression model. The developed nomogram was internally validated with bootstrapping, and performance was assessed by concordance index and a calibration curve. External validation was also performed using an independent data set of patients from Asan Medical Center.
RESULTS: From Cox regression analysis, disease stage, number of positive lymph nodes, parametrial involvement, and depth of invasion were identified as independent risk factors for disease recurrence (P < 0.05). The nomogram incorporating these factors appeared to be accurate and predicted the outcomes better than the International Federation of Gynecology and Obstetrics stage alone (concordance index, 0.858 compared with 0.719; P = 0.001). When applied to a separate validation set, the nomogram also showed similar predictive accuracy (concordance index, 0.879).
CONCLUSION: We have developed a nomogram that can predict the recurrence risk in patients with early-stage cervical cancer after surgery, which was internally and externally validated.

Entities:  

Mesh:

Year:  2010        PMID: 21370600

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  16 in total

1.  The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

Authors:  David Cibula; Lukáš Dostálek; Jiri Jarkovsky; Constantijne H Mom; Aldo Lopez; Henrik Falconer; Anna Fagotti; Ali Ayhan; Sarah H Kim; David Isla Ortiz; Jaroslav Klat; Andreas Obermair; Fabio Landoni; Juliana Rodriguez; Ranjit Manchanda; Jan Kosťun; Ricardo Dos Reis; Mehmet M Meydanli; Diego Odetto; Rene Laky; Ignacio Zapardiel; Vit Weinberger; Klára Benešová; Martina Borčinová; Darwin Pari; Sahar Salehi; Nicolò Bizzarri; Huseyin Akilli; Nadeem R Abu-Rustum; Rosa A Salcedo-Hernández; Veronika Javůrková; Jiří Sláma; Luc R C W van Lonkhuijzen
Journal:  Eur J Cancer       Date:  2021-10-16       Impact factor: 10.002

2.  Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: An observational study with a long-term follow-up.

Authors:  Jing Zuo; Ying Huang; Jusheng An; Xi Yang; Ning Li; Manni Huang; Lingying Wu
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

3.  Nomogram prediction for overall survival of patients diagnosed with cervical cancer.

Authors:  S Polterauer; C Grimm; G Hofstetter; N Concin; C Natter; A Sturdza; R Pötter; C Marth; A Reinthaller; G Heinze
Journal:  Br J Cancer       Date:  2012-08-07       Impact factor: 7.640

4.  Long non-coding RNA HOTAIR is associated with human cervical cancer progression.

Authors:  Hee Jung Kim; Dae Woo Lee; Ga Won Yim; Eun Ji Nam; Sunghoon Kim; Sang Wun Kim; Young Tae Kim
Journal:  Int J Oncol       Date:  2014-11-17       Impact factor: 5.650

5.  Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer.

Authors:  Jeanny Kwon; Keun-Yong Eom; In Ah Kim; Jae-Sung Kim; Young-Beom Kim; Jae Hong No; Kidong Kim
Journal:  Cancer Res Treat       Date:  2015-07-14       Impact factor: 4.679

6.  NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.

Authors:  Chunhao Niu; Xiaoying Sun; Weijing Zhang; Han Li; Liqun Xu; Jun Li; Benke Xu; Yanna Zhang
Journal:  Int J Mol Sci       Date:  2016-10-20       Impact factor: 5.923

7.  Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.

Authors:  Won Sup Yoon; Dae Sik Yang; Jung Ae Lee; Nam Kwon Lee; Young Je Park; Chul Yong Kim; Nak Woo Lee; Jin Hwa Hong; Jae Kwan Lee; Jae Yun Song
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

8.  Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.

Authors:  Weiwei Zhang; Kejun Liu; Bin Ye; Weijiang Liang; Yazhou Ren
Journal:  Cancer Med       Date:  2017-11-28       Impact factor: 4.452

Review 9.  Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer.

Authors:  Yue-Mei Jin; Shan-Shan Liu; Jun Chen; Yan-Nan Chen; Chen-Chen Ren
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

10.  Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?

Authors:  U Chul Ju; Woo Dae Kang; Seok Mo Kim
Journal:  J Gynecol Oncol       Date:  2018-03-20       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.